Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Phase 3 Papulopustular Rosacea Study

ClinicalTrials.gov ID: NCT01494467

Public ClinicalTrials.gov record NCT01494467. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 10:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Double Blind, 12 Week Vehicle Controlled, Parallel Group Study Assessing the Efficacy and Safety of CD5024 1 % Cream Versus Vehicle Cream in Subjects With Papulopustular Rosacea, Followed by a 40 Week Investigator Blinded Extension Comparing the Long Term Safety of CD5024 1% Cream Versus Azelaic Acid 15 % Gel.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to demonstrate that CD5024 1% cream is more effective than its vehicle when applied once daily, at bed time, during a 12 week period in subjects with Papulopustular Rosacea (PPR) and continues to be safe up to 12 months.

Study identification

NCT ID
NCT01494467
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Galderma R&D
Industry
Enrollment
688 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2011 (Type not available)
Primary completion
Aug 2013 (Actual)
Completion
Aug 2013 (Actual)
Last update posted
Feb 18, 2021

2011 – 2013

United States locations

U.S. sites
40
U.S. states
19
U.S. cities
39
Facility City State ZIP Site status
Total Skin and Beauty Birmingham Alabama 35205 —
Coastal Clinical Research, Inc. Mobile Alabama 36608 —
Burke Pharmaceutical Research Hot Springs Arkansas 71913 —
Dermatology Specialists, Inc Oceanside California 92056 —
Integrated Research Group, Inc Riverside California 92506 —
Therapeutics Clinical Research San Diego California 92123 —
University of California, San Francisco San Francisco California 94143 —
ATS Clinical Research Santa Monica California 90404 —
Redwood Dermatology Research Santa Rosa California 95403 —
FXM Research Corp Miami Miami Florida 33175 —
Leavitt Medical Associates of Florida dba Ameriderm Research Ormond Beach Florida — —
Atlanta Dermatology, Vein & Research Center, LLC Alpharetta Georgia 30022 —
Emory University Atlanta Georgia 30322 —
Altman Dermatology Associates Arlington Heights Illinois 60005 —
Northwestern University Chicago Illinois 60611 —
Deaconess Clinic, Inc. Evansville Indiana 47713 —
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46256 —
Dermatology Specialists Research Louisville Kentucky 40202 —
Northeast Dermatology Associates Beverly Massachusetts 01915 —
David Fivenson, MD, PLC Ann Arbor Michigan 48103 —
Hamzavi Dermatology Fort Gratiot Michigan 48059 —
Somerset Skin Centre Troy Michigan 48084 —
Dermatology Clinical Trials Unit St Louis Missouri 63141 —
Psoriasis Treatment Center of NJ West Windsor New Jersey — —
Academic Dermatology Associates Albuquerque New Mexico 87106 —
DermResearch Center of New York, Inc Stony Brook New York 11790 —
Not listed High Point North Carolina 27262 —
PMG Research of Raleigh, LLC Raleigh North Carolina 27609 —
Oregon Dermatology and Research Center Portland Oregon 97210 —
Dermatology and Skin Surgery Center Exton Pennsylvania 19341 —
Philadelphia Institute of Dermatology Fort Washington Pennsylvania 19034 —
Penn State Hershey Medical Center Hershey Pennsylvania 17033 —
Paddington Research Philadelphia Pennsylvania 19103 —
Yardley Dermatology Associates Yardley Pennsylvania 19067 —
The Skin Wellness Center Knoxville Tennessee 37922 —
Dermatology Reserach Associates Nashville Tennessee 17203 —
Arlington Research Center, Inc Arlington Texas 76011 —
Stephen Miller MD San Antonio Texas 78229 —
Not listed San Antonio Texas 78229 —
Center for Clinical Studies Webster Texas 77598 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01494467, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 18, 2021 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01494467 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →